Keywords: Johnson &Johnson, Crucell, Merger and acquisiton, Monoclonal, Vaccines

Johnson & Johnson to acquire 18% stake in Crucell and collaborate on MAbs and vaccines

Article | 28 September 2009

US health care major Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals, has entered into a strategic collaboration with Netherlands-based Crucell ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Johnson & Johnson

Go to company listing